BAYER SAYS POSITIVE RESULTS FROM PHASE III STUDY OASIS 3 SUPPORT SUBMISSIONS FOR MARKETING AUTHORIZATION FOR ELINZANETANT
Bayer Says Positive Results From Phase Iii Study Oasis 3 Support…
![Reuters logo](/images/reuters.jpg)
BAYER SAYS POSITIVE RESULTS FROM PHASE III STUDY OASIS 3 SUPPORT SUBMISSIONS FOR MARKETING AUTHORIZATION FOR ELINZANETANT
Price
|
Change
|
5d. change
|
Capi.
| ||
---|---|---|---|---|---|
26.06 EUR | -1.25% | +2.78% | 28.29B | ||
2,904 PTS | +0.34% | +0.31% | - | ||